Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose primaquine added to artemether-lumefantrine for uncomplicated malaria
PACTR201611001859416Completed
- Sponsor
- University of Cape Town
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of primaquine and artemether + lumefantrine in malaria (2 arms), sponsored by University of Cape Town. Started Nov 2016; status: completed.
02
Drugs
primaquineartemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201611001859416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201611001859416.